The challenge isn’t just access to fertility benefits, it’s how those benefits are structured and delivered. Here are three emerging themes that can help employers better align cost, quality and experience. The post The Smart Way to Build the Future of Fertility Benefits appeared first on MedCity News .
The positive ripple effect of high specimen sensitivity influences the clarity of diagnoses, the timing of treatment and the efficiency of care delivery across systems, while also protecting communities from further disease spread for stronger outbreak control. The post Shifting Our Focus to Sample Sensitivity: The Metric That Deserves More Attention in Respiratory Care appeared first on MedCity News .
Big cuts to healthcare programs in the 2025 GOP budget law are creating an affordability crunch for many Americans: Higher health insurance premiums. Confusion about whom Medicaid will cover under the new rules. KFF Health News chief Washington correspondent Julie Rovner explains how the changes could leave nearly 2 million children uninsured.
Come January, pregnancy care physician billing codes will change from a bundled system to an à la carte one. Many obstetricians say this approach will better reflect the amount and type of care they provide. But it could incentivize providers to pile on visits and services.
Travel bans and conflict have disrupted supply chains in the Democratic Republic of Congo, leaving health workers without Ebola tests and protective gear needed to contain the outbreak.
One Nation, Overcharged, a campaign backed by the Robert Wood Johnson Foundation, launched to raise awareness of rising healthcare costs. The post What the ‘One Nation, Overcharged’ Campaign Aims to Achieve appeared first on MedCity News .
Ona Therapeutics’ antibody drug conjugates come from a platform technology that discovers novel antigens intended to enable the therapies to overcome drug resistance. The Spain-based startup’s lead ADC is on track to begin clinical testing in breast cancer. The post Startup Secures $86M to Take On One of the Challenges for ADCs in Breast Cancer appeared first on MedCity News .
CereVasc raised $85 million in Series C funding to advance its minimally invasive eShunt system, which aims to treat hydrocephalus without traditional brain shunt surgery. The company is preparing for a pivotal trial completion and FDA submission in 2027. The post CereVasc Rakes In $85M to Challenge Traditional Brain Shunt Surgery appeared first on MedCity News .
MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, Managing Partner of Health Innovation Pitch, co-hosts of the Debunked Podcast, discussed the impact of Marty Makary’s resignation from the FDA, among other topics. The post Debunked Episode 27: The Impact of an FDA Commissioner’s Departure, Insider Trading, Microdosing GLP-1s and a Win for Lower Drug Prices appeared first on MedCity News .
Millennials and Gen Z are more likely to engage earlier, seek care proactively, and continue treatment over time. A mental health diagnosis is more likely to represent active management, not a late-stage recognition of a problem that has already compounded. The post The Generational Inversion in Employer Health Costs That Most CFOs Aren’t Seeing appeared first on MedCity News .
Replacing a paper clipboard with a QR code on your phone doesn’t kill the clipboard; it’s just a better clipboard. Why? The burden is still on the patient. It’s the digital version of carrying a manila folder of records across town. This is a half-measure. It’s not true interoperability. The post Kill the Clipboard Tax appeared first on MedCity News .
AI can speed up drug discovery and decrease attrition rates in the clinic, but it is important to recognize that both are tall orders. The companies that will benefit most are those that stay grounded, set realistic expectations, and keep experienced scientists at the center of decisions that require genuine creativity and judgment. The post AI in Drug Discovery: Surveying the Breadth of the Challenges appeared first on MedCity News .